Senate backs opioid levy; Scott doesn’t

The levy would be based on the drug manufacturers’ sales in the state. Creative Commons photo
The state Senate on Thursday supported imposing a new financial assessment on opioid manufacturers, soundly defeating efforts to eliminate or modify the controversial levy.
The assessment, to be divided among manufacturers according to the amount of opioids each has distributed in Vermont, is expected to generate millions of dollars for drug prevention and addiction-treatment programs.Get all of V